Cindy Jacobson

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Jared M. Baeten, Thesla Palanee‐Phillips, Elizabeth R. Brown et al. · Obstetrical & Gynecological Survey · 2016 · 373 citations

Medicine, Infectious Diseases, Preventive Medicine +15

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

Ian McGowan, Kailazarid Gomez, Karen Bruder et al. · AIDS · 2011 · 125 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +15

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi et al. · The Lancet HIV · 2021 · 111 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Ross Cranston, Javier R. Lama, Barbra A. Richardson et al. · Clinical Infectious Diseases · 2016 · 61 citations · Full text

Public Health, Pharmacotherapy, Sexuality Studies +15

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

Gonasagrie Nair, Connie Celum, Daniel Szydlo et al. · The Lancet HIV · 2023 · 60 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17